Skip to main content
Hanshang Group Co.,Ltd. logo

Hanshang Group Co.,Ltd. — Investor Relations & Filings

Ticker · 600774 ISIN · CNE000000NC5 Shanghai Stock Exchange Wholesale and retail trade
Filings indexed 1,570 across all filing types
Latest filing 2022-04-13 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 600774

About Hanshang Group Co.,Ltd.

https://www.whhsg.com/

Hanshang Group Co.,Ltd. is a diversified enterprise focused on commercial operations, exhibition services, and healthcare. The company manages a portfolio of large-scale department stores, shopping malls, and specialized retail outlets. Its exhibition segment provides comprehensive venue management and event organization services for international and domestic trade fairs. Hanshang Group has significantly expanded its presence in the healthcare sector through the development and distribution of pharmaceuticals, medical devices, and health-related products. By integrating traditional commercial assets with modern biomedical research and health management services, the group targets a broad consumer base and professional medical markets, emphasizing a strategic transition toward a comprehensive health-oriented business model.

Recent filings

Filing Released Lang Actions
中信证券股份有限公司关于武汉市汉阳投资发展集团有限公司免于以要约方式收购汉商集团股份有限公司之2021年度持续督导意见
Regulatory Filings
2022-04-13 Chinese
中信建投证券股份有限公司关于汉商集团股份有限公司重大资产购买之2021年度业绩承诺实现情况的核查意见
Audit Report / Information Classification · 95% confidence The document is a verification opinion from an independent financial advisor regarding the achievement of performance commitments related to a major asset purchase by a listed company. It includes audited financial figures for 2020 and 2021, comparing committed net profits to actual results, and concludes that the performance commitments have been met. The content focuses on the verification of financial performance related to a specific transaction rather than presenting a full annual or interim report, earnings release, or other types of filings. This type of document aligns with an Audit Report / Information (AR) as it involves a special audit report on performance commitments related to a major asset acquisition, including financial data and audit conclusions but is not a full annual report or earnings release. The document length is short (1161 characters), but it contains substantive financial data and audit opinion, so it is not a mere announcement or certification. Therefore, the appropriate classification is AR with high confidence. FY 2021
2022-04-08 Chinese
中信建投证券股份有限公司关于汉商集团股份有限公司重大资产购买之2021年度持续督导意见暨持续督导总结报告
Regulatory Filings
2022-04-08 Chinese
汉商集团关于全资子公司迪康药业股份被解除保全措施的公告
Regulatory Filings Classification · 95% confidence The document is an official announcement by 汉商集团股份有限公司 regarding the lifting of a preservation measure on shares of its wholly-owned subsidiary, 成都迪康药业股份有限公司. It details a court ruling and legal procedural information about the lifting of a freeze on shares. The content is focused on legal and regulatory updates related to the company's shareholding and court decisions, not on financial results, management changes, or shareholder voting. The document is relatively short (1820 characters) and is a formal announcement of a legal event affecting the company. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories like Legal Proceedings Report (LTR) because it is not a lawsuit update but a court ruling announcement related to share preservation measures.
2022-04-06 Chinese
汉商集团2021年度股东大会会议材料
AGM Information Classification · 100% confidence The document is titled as "2021 年年度股东大会 会议文件" which translates to "2021 Annual General Meeting (AGM) Meeting Materials." It contains detailed agenda items for the 2021 AGM, including the annual report, board work report, financial statements, supervisory board report, independent directors' report, profit distribution proposals, and other resolutions to be discussed and voted on at the AGM. The document includes meeting instructions, agenda, and detailed reports and proposals to be presented at the AGM. It is clearly a set of materials prepared for the Annual General Meeting rather than the annual report itself or an announcement of the report. The length and detail confirm it is not a brief announcement or a certification. Therefore, the document fits the category of AGM Information (AGM-R).
2022-04-06 Chinese
汉商集团关于延期召开2021年度业绩说明会的公告
Investor Presentation Classification · 85% confidence The document is an announcement regarding the postponement of the 2021 annual performance explanation meeting (业绩说明会) originally scheduled for April 8, 2022, now postponed to April 15, 2022. It details the meeting time, location, format (online interaction), participants, and how investors can participate and ask questions. The document references the 2021 annual report having been published on March 31, 2022, but this document itself is not the report or a transcript of the meeting. It is a notice about the scheduling of an investor presentation event focused on discussing the annual results. Therefore, this document is best classified as an Investor Presentation (IP) announcement or notice. However, since it is primarily an announcement of the meeting and not the presentation materials themselves, and given the short length (1528 characters), it fits the category of Report Publication Announcement (RPA) or Regulatory Filings (RNS). But the content is specifically about an investor meeting to explain annual results, which aligns with Investor Presentation (IP). Given the detailed description of the meeting and its interactive nature, the best fit is Investor Presentation (IP).
2022-04-06 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.